Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii

Meric, 2008, Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey, FEMS Microbiol Lett, 282, 214, 10.1111/j.1574-6968.2008.01129.x

Valenzuela, 2007, Horizontal gene transfer within a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii, J Clin Microbiol, 45, 453, 10.1128/JCM.01971-06

Bell, 2004, Antibiotic Susceptibility Testing by the CDS Method. A Manual for Medical and Veterinary Laboratories

Ericsson, 1971, Antibiotic sensitivity testing. Report of an international collaborative study, Acta Pathol Microbiol Scand [B] Microbiol Immunol, 217, 1

European Committee on Antimicrobial Susceptibility Testing (EUCAST), Expert Rules in Antimicrobial Susceptibility Testing, Version 1

White, 2000, Characterisation of two new gene cassettes, aadA5 and dfrA17, FEMS Microbiol Lett, 182, 265, 10.1111/j.1574-6968.2000.tb08906.x

White, 2001, Integrons and gene cassettes in the Enterobacteriaceae, Antimicrob Agents Chemother, 45, 2658, 10.1128/AAC.45.9.2658-2661.2001

Guardabassi, 2000, Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains, J Med Microbiol, 49, 929, 10.1099/0022-1317-49-10-929

Woodford, 2006, Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp, Int J Antimicrob Agents, 27, 351, 10.1016/j.ijantimicag.2006.01.004

Heritier, 2006, Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii, Clin Microbiol Infect, 12, 123, 10.1111/j.1469-0691.2005.01320.x

Bull, 2006, Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis, J Clin Microbiol, 44, 327, 10.1128/JCM.44.2.327-333.2006

Vila, 1995, Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii, Antimicrob Agents Chemother, 39, 1201, 10.1128/AAC.39.5.1201

Bou, 2000, PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii, Clin Microbiol Infect, 6, 635, 10.1046/j.1469-0691.2000.00181.x

Yanisch-Perron, 1985, Improved M13 phage cloning vectors and host trains: nucleotide sequences of the M13mp18 and pUC19 vectors, Gene, 33, 103, 10.1016/0378-1119(85)90120-9

Fournier, 2006, Comparative genomics of multidrug resistance in Acinetobacter baumannii, PLoS Genet, 2, e7, 10.1371/journal.pgen.0020007

Oka, 1981, Nucleotide sequence of the kanamycin resistance transposon Tn903, J Mol Biol, 147, 217, 10.1016/0022-2836(81)90438-1

Corvec, 2003, AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains, J Antimicrob Chemother, 52, 629, 10.1093/jac/dkg407

Segal, 2004, Genetic environment of ampC in an Acinetobacter baumannii clinical isolate, Antimicrob Agents Chemother, 48, 612, 10.1128/AAC.48.2.612-614.2004

Bush, 1995, A functional classification scheme for β-lactamases and its correlation with molecular structure, Antimicrob Agents Chemother, 39, 1211, 10.1128/AAC.39.6.1211

Afzal-Shah, 2001, Characterization of OXA-25, OXA-26 and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii, Antimicrob Agents Chemother, 45, 583, 10.1128/AAC.45.2.583-588.2001

Heritier, 2005, Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii, Antimicrob Agents Chemother, 49, 3198, 10.1128/AAC.49.8.3198-3202.2005

Donald, 2000, Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92, Antimicrob Agents Chemother, 44, 196, 10.1128/AAC.44.1.196-199.2000

Turton, 2006, The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii, FEMS Microbiol Lett, 258, 72, 10.1111/j.1574-6968.2006.00195.x

Smith, 2007, New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis, Genes Dev, 21, 601, 10.1101/gad.1510307

Iacono, 2008, Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group, Antimicrob Agents Chemother, 52, 2616, 10.1128/AAC.01643-07

Vallenet, 2008, Comparative analysis of Acinetobacters: three genomes for three lifestyles, PLoS ONE, 3, e1805, 10.1371/journal.pone.0001805

Nemec, 2004, Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones, J Med Microbiol, 53, 1233, 10.1099/jmm.0.45716-0

Kraniotaki, 2006, Molecular investigation of an outbreak of multidrug-resistant Acinetobacter baumannii, with characterisation of class 1 integrons, Int J Antimicrob Agents, 28, 193, 10.1016/j.ijantimicag.2006.04.016

Turton, 2004, A prevalent, multiresistant clone of Acinetobacter baumannii in South East England, J Hosp Infect, 58, 170, 10.1016/j.jhin.2004.05.011

Turton, 2005, Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom, J Clin Microbiol, 43, 3074, 10.1128/JCM.43.7.3074-3082.2005

Barrow, 2004, Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim, Antimicrob Agents Chemother, 48, 4643, 10.1128/AAC.48.12.4643-4649.2004

Then, 1979, Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases, Antimicrob Agents Chemother, 15, 1, 10.1128/AAC.15.1.1

Flensburg, 1987, Massive overproduction of dihydrofolate reductase in bacteria as a response to the use of trimethoprim, Eur J Biochem, 162, 473, 10.1111/j.1432-1033.1987.tb10664.x

Skold, 2001, Resistance to trimethoprim and sulfonamides, Vet Res, 32, 261, 10.1051/vetres:2001123